Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(11%)
Results Posted
43%(3 trials)

Phase Distribution

Ph phase_2
1
11%
Ph phase_3
1
11%
Ph phase_1
1
11%
Ph not_applicable
6
67%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(7)
Other(1)

Detailed Status

Completed7
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (11.1%)
Phase 21 (11.1%)
Phase 31 (11.1%)
N/A6 (66.7%)

Trials by Status

unknown111%
completed778%
recruiting111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
9